Studies utilizing BMA-enriched mouse models found upregulated levels of FABP4 in Prostate Cancer(PCa) cells directly in contact with BMAs, suggesting a bidirectional interaction between FABP4 and the PPARγ pathway may enhance the invasiveness of tumor cells in bone metastasis (121). This evidence concerns the gene FABP4 and prostate carcinoma.